Hypoxia-induced PRMT6 expression promotes temozolomide chemoresistance in glioblastoma via G3BP1
This study provides evidence that hypoxia mediates TMZ resistance in GBM through the HIF-1α/PRMT6/G3BP1 axis, identifying PRMT6 and G3BP1 as promising therapeutic targets to overcome chemoresistance.
Authors
- S S Chen
- Guangyu Li (ORCID: https://orcid.org/0000-0002-6338-2507)
- Peng Yu
- Boxiang Zhang
- Yuting Yan
- Yongqing Sun
Institutions
- First Hospital of China Medical University (CN)
- China Medical University (CN)
Publication Details
- Journal
- Journal of Translational Medicine
- Published
- 2026-01-02
- DOI
- https://doi.org/10.1186/s12967-025-07618-5
- Primary Topic
- Cancer-related gene regulation
- Type
- article
- Field-Weighted Citation Impact
- 0.00